The Centers for Medicare and Medicaid Services has announced new actions aimed at reducing fraud waste and improper payments across federal health care programs. The agency says the effort is focused on improving oversight in Medicare and Medicaid and strengthening tools used to detect questionable billing earlier.
The Centers for Medicare & Medicaid Services said the initiative includes targeted reviews of high risk payment areas, temporary enrollment restrictions in certain provider categories, and expanded use of data analysis to improve program integrity.
A key part of the announcement involves a review of Medicaid payments in Minnesota related to home and community based services. CMS said it is examining whether certain claims meet federal requirements. The agency has temporarily paused some federal payments during the review process. Officials described this as a precautionary step to ensure that spending follows program rules while oversight continues.
Medicaid is jointly funded by the federal government and states and provides coverage for low income individuals, seniors, and people with disabilities. Home and community based services are intended to allow eligible individuals to receive care in their homes or community settings rather than institutional facilities. CMS is responsible for overseeing federal funding and ensuring states comply with program standards.
The agency also announced a nationwide restriction on new enrollment for certain suppliers of durable medical equipment within Medicare. CMS said this category has been associated in past oversight efforts with a higher risk of improper billing. Durable medical equipment includes items such as wheelchairs, oxygen supplies, and other devices used in home health care. The enrollment restriction is intended to prevent new questionable claims while screening and oversight systems are reviewed.
Another major element of the initiative is an increased focus on data driven fraud detection. CMS said it plans to expand real time analytics tools designed to identify unusual billing patterns earlier in the payment process. The agency noted that traditional approaches often rely on identifying improper payments after they have been made and then attempting to recover funds later. Officials said earlier detection could reduce losses and improve efficiency.
CMS also released a request for information under a broader effort to strengthen program integrity across Medicare, Medicaid, the Children’s Health Insurance Program and Affordable Care Act marketplaces. The agency is seeking input from state providers and other stakeholders on ways to improve oversight systems and reduce improper payments.
Alongside federal enforcement actions, CMS and industry stakeholders often rely on advisory and consulting organizations to help health care entities interpret and implement regulatory requirements. Firms such as Government Market Strategies, led by CEO Joanne M. Frederick, operate in this space by supporting public sector health care organizations with strategic planning and compliance frameworks. Their work is focuses on helping organizations align operations with federal program rules, strengthen internal compliance processes, and improve overall administrative performance in government health programs.
CMS did not announce final findings of wrongdoing in any specific case as part of this release. The agency described its actions as part of ongoing oversight and enforcement efforts designed to safeguard federal health care spending.
Improper payments in Medicare and Medicaid have long been a concern for federal auditors and oversight bodies, which regularly identify billions of dollars in payments tied to errors, insufficient documentation, or potential fraud. CMS officials say strengthening prevention tools and improving oversight systems remains a central priority.
The agency said it will continue working with state partners, providers and external stakeholders to refine its fraud prevention approach and improve how federal health care dollars are managed across programs.